<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60278">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01758835</url>
  </required_header>
  <id_info>
    <org_study_id>OYSrctAnkle5</org_study_id>
    <nct_id>NCT01758835</nct_id>
  </id_info>
  <brief_title>Evaluation of Different Non-operative Treatment Protocols of ER-stress Negative Weber-B Unimalleolar Ankle Fractures. A Multicenter Trial</brief_title>
  <official_title>Evaluation of Different Non-operative Treatment Protocols of ER-stress Negative Weber-B Unimalleolar Ankle Fractures. A Prospective Randomized Multicenter Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <authority>Finland: Valvira - National Supervisory Authority for Welfare and Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized controlled multicenter study to evaluate non-operative treatment
      protocols for treating ER-stress negative unimalleolar Weber-B type fibular fractures.
      Groups are: 1. 3 weeks in a removable splint 2. 3 weeks in a cast and 3. 6 weeks in a cast.
      Follow-up visits at 3, 6 and 12 weeks and after 1 and 2 years after injury. In each time
      X-rays laterally and mortise projections. Guestionnaires: RAND-36, VAS, Olerud-Molander and
      FAOS in follow up-visits 6 and 12 weeks and 1 and 2 year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>RAND-36</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>FAOS</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Olerud-Molander</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Fracture healing</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">246</enrollment>
  <condition>ER-stress-test Negative Unimalleolar Fibula Weber-B Fractures</condition>
  <arm_group>
    <arm_group_label>Splint 3 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cast 3 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cast 6 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Splint 3 weeks</intervention_name>
    <arm_group_label>Splint 3 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cast 3 weeks</intervention_name>
    <arm_group_label>Cast 3 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cast 6 weeks</intervention_name>
    <arm_group_label>Cast 6 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable Weber-B type fibula fracture

          -  ER-stress negative

          -  16 or over years old

          -  Willingness to participate on study proved by a signature and date

          -  Walking without aid before accident

          -  Treatment started within 7 days from injury

        Exclusion Criteria:

          -  Prior ankle fracture or significant fracture in the area of ankle or leg

          -  Bilateral ankle fracture

          -  Pathological fracture

          -  Diabetes mellitus or an other significant periferial neuropathy

          -  municipality of Residence in some else catchment area than Oulu university  hospital
             or Tampere university hospital

          -  Patient's understanding or co-operation inadequate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harri Juhani Pakarinen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harri Juhani Pakarinen, MD, PhD</last_name>
    <phone>+35883152806</phone>
    <email>harri.pakarinen@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tero Heikki Juhana Heikki Kortekangas, MD</last_name>
    <phone>+3583155995</phone>
    <email>tero.kortekangas@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>OYS, kirurgian klinkka, Oulu</name>
      <address>
        <city>Oulu</city>
        <zip>90100</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harri Juhani Pakarinen, MD, Phd</last_name>
      <phone>+35883152806</phone>
      <email>harri.pakarinen@ppshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Tero Heikki Juhana Kortekangas, MD</last_name>
      <phone>+35883152011</phone>
      <email>tero.kortekangas@ppshp.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 31, 2012</lastchanged_date>
  <firstreceived_date>December 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Harri Pakarinen</investigator_full_name>
    <investigator_title>Orthopedic surgeon, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>ER-stress-test negative</keyword>
  <keyword>unimalleolar</keyword>
  <keyword>fibula</keyword>
  <keyword>Weber-B fractures</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
